Cubist Pharmaceuticals, Inc. Selects TransPerfect Trial Interactive’s Trial Interactive Platform As Its eTMF Solution

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK--(BUSINESS WIRE)--TransPerfect, a leading provider of e-clinical solutions and language services to the life sciences industry, today announced that Cubist has selected Trial Interactive as their electronic Trial Master File (eTMF) enterprise solution across several clinical programs. Trial Interactive is a web-based, 21 CFR Part 11 compliant platform that integrates clinical documentation and trial development.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC